Luye Pharma Launches Erzofri in US Market
CompanyDrug

Luye Pharma Launches Erzofri in US Market

Novo Nordisk's Semaglutide 7.2 mg Shows Superior Weight Loss in Phase III Study
CompanyDrug

Novo Nordisk’s Semaglutide 7.2 mg Shows Superior Weight Loss in Phase III Study

Xinzeyuan Medical Raises Series B+ Funding for Surgical Supply Chain
CompanyDeals

Xinzeyuan Medical Raises Series B+ Funding for Surgical Supply Chain

Zai Lab's KarXT NDA Accepted by NMPA for Schizophrenia Treatment
CompanyDrug

Zai Lab’s KarXT NDA Accepted by NMPA for Schizophrenia Treatment

Frontier Biotechnologies Gains NMPA Approval for Albuvirtide Phase II Study
CompanyDrug

Frontier Biotechnologies Gains NMPA Approval for Albuvirtide Phase II Study

Wanbangde's Huperzine A Receives FDA Clearance for HIE Study
CompanyDrug

Wanbangde’s Huperzine A Receives FDA Clearance for HIE Study

FDA Approves Datroway for HR+/HER2- Breast Cancer Treatment
CompanyDrug

FDA Approves Datroway for HR+/HER2- Breast Cancer Treatment

Allist Pharmaceuticals Gains NMPA Approval for Furmonertinib Clinical Study
CompanyDrug

Allist Pharmaceuticals Gains NMPA Approval for Furmonertinib Clinical Study

NHSA Seeks Expert Opinions on VBP Drug Quality and Efficacy
Policy / Regulatory

NHSA Seeks Expert Opinions on VBP Drug Quality and Efficacy

Junshi Biosciences' Toripalimab Gains TGA Approval for Nasopharyngeal Carcinoma
CompanyDrug

Junshi Biosciences’ Toripalimab Gains TGA Approval for Nasopharyngeal Carcinoma

Inscinstech Secures C-Series Financing for Biopharma Expansion
Company

Inscinstech Secures C-Series Financing for Biopharma Expansion

Raytone Bio Completes Angel Round to Advance iSus® Platform
Company

Raytone Bio Completes Angel Round to Advance iSus® Platform